过去12年中已有作者研究了抗心律失常药物的血浓度与预防心源性猝死之间的关系。少数研究已明确显示,如果药物血浓度在治疗范围则能提高生存率。本文作者应用安搏律定(Aprindine)对室性心动过速和心室颤动(以下简称为室速和室颤)的生存者进行长期治疗,通过对药物血浓度和临床反应的观察,进一步阐明两者关系。 In the past 12 years, authors have studied the relationship between the blood levels of anti-arrhythmic drugs and the prevention of sudden cardiac death. A few studies have clearly shown that if the drug blood concentration in the treatment range can increase the survival rate. The authors apply long-term treatment of survivors of ventricular tachycardia and ventricular fibrillation (hereinafter referred to as ventricular fibrillation and ventricular fibrillation) with Aprindine and further elucidate the effects of both relationship.